Reduced total plasma homocyst(e)ine in children and adolescents with type 1 diabetes

Journal of Pediatrics

Volumn 138, Issue 6, 2001, Pages 888-893

  Wiltshire, Esko ^a,b   Thomas, David W ^a,b   Baghurst, Peter ^a,b   Couper, Jennifer ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTINE;

ADOLESCENT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET RESTRICTION; DIETARY INTAKE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0034974813     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.113708     Document Type: Article

References (47)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
2. Homocysteine and atherothrombosis
3. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
4. Oxidative stress and diabetic vascular complications
5. Dysfunction of the vascular endothelium in diabetes mellitus
6. Homocysteinemia: Vascular injury and arterial thrombosis
7. Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis
8. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
9. Activation of hageman factor by L-homocysteine
10. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
11. Homocysteine, an atherogenic stimulus, reduces protein kinase C activation by arterial and venous endothelial cells
12. Inhibition of thrombomodulin surface expression and protein C activation by the thrombotic agent homocysteine
13. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor in endothelial cells
14. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulphate expression in cultured porcine aortic endothelial cells
15. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons
16. Disorders of homocysteine metabolism
17. A candidate genetic risk factor for vascular disease: A common mutation in methylene tetrahydrofolate reductase
18. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?
19. Relation between folate status, a common mutation in methylene tetrahydrofolate reductase and plasma homocysteine concentrations
20. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM
21. Total homocysteine in patients with type 1 diabetes
22. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes
23. Defective homocysteine metabolism as a risk factor for diabetic retinopathy
24. Methylene tetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients
25. Type 1 diabetes mellitus and homocyst(e)ine
26. Plasma homocysteine concentrations in patients with type 1 diabetes
27. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus
28. Plasma homocysteine and all-cause mortality in diabetes
29. Reference ranges for total homocysteine in children
30. Distribution of and factors associated with serum homocysteine levels in children. Child and adolescent trial for cardiovascular health
31. Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children. The Bogalusa heart study
32. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives
33. Plasma homocysteine concentrations in a Belgian school-age population
34. Selective screening for hyperhomocysteinemia in pediatric patients
35. Endothelial dysfunction precedes development of microalbuminuria in IDDM
36. Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM
37. Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM
38. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abott IMx analyzer
39. Measurement and use of total plasma homocysteine
40. Association of lipoprotein (a) and puberty in IDDM
41. Enzymic assay of creatinine in serum and urine with creatinine iminohydrolase and glutamate dehydrogenase
42. Estimation of glomerular filtration from plasma creatinine concentration in children
43. A computerised dietary analysis system for use with diet diaries of food frequency questionnaires
44. Whole blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: Differences between the radioassay and microbiological assays
45. Regulation of homocysteine metabolism
46. The effect of glucose and insulin on the activity of enzymes in homocysteine metabolism
47. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects